Eli Lilly announced a new $27bn US manufacturing commitment on 26 February alongside top Trump Administration officials at the Andrew W. Mellon Auditorium in Washington DC. (Sarah Karlin-Smith)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
